Inflammatory pathway regulation

Inflammatory pathway regulation refers to the complex network of molecular signaling cascades and feedback mechanisms that control the initiation, amplification, and resolution of inflammation. Key pathways include NF-κB, MAPK, and JAK-STAT, which integrate signals from cytokines, pattern recognition receptors, and other mediators to coordinate immune responses. Therapeutic strategies often focus on targeting specific molecules within these pathways to treat inflammatory and autoimmune diseases, cancer, and other pathologies associated with dysregulated inflammation. However, because 'inflammatory pathway regulation' is not a single protein or receptor, but encompasses a broad range of processes, it is not a canonical drug target in itself[1][2][7].

Inhibition or modulation of key inflammatory mediators (e.g., cytokine antagonists, kinase inhibitors); Suppression of pro-inflammatory signaling